Second, it is possible that we missed pathogenic germline variants in moderate penetrance colorectal cancer genes such as ATM, SMAD3, or high penetrance syndromes primarily associated with other cancers such as BRCA1 and BRCA2, which were not part of our panel. This evidence concerns the gene BRCA1 and cancer.